Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Medicines Ppis'

Medicines Ppis published presentations and documents on DocSlides.

Good g overnance in the pharmaceutical

Good g overnance in the pharmaceutical

  • trish-goza
  • 0 Slides

sector. . Cécile . Macé. Department of Essenti...

Access to affordable and quality assured essential medicines

Access to affordable and quality assured essential medicines

  • ellena-manuel
  • 0 Slides

Gilles Forte. Policy. , Access and Use Team. Depa...

Improving access to controlled medicines

Improving access to controlled medicines

  • conchita-marotz
  • 0 Slides

Gilles . Forte. Coordinator, Policy, Access and U...

NHS West Lancashire CCG – Strategy, Vision & Operational Update

NHS West Lancashire CCG – Strategy, Vision & Operational Update

  • calandra-battersby
  • 0 Slides

Paul Kingan, Chief Finance Officer. 112,000 popul...

Advancing Patient Engagement through Coalition Partnerships

Advancing Patient Engagement through Coalition Partnerships

  • trish-goza
  • 0 Slides

2nd Annual . Optimizing Patient Adherence Confere...

Responsible and appropriate (rational) use of medicines

Responsible and appropriate (rational) use of medicines

  • phoebe-click
  • 0 Slides

Dr Jane Robertson. Policy, Access and Use Team, E...

Value of generic medicines

Value of generic medicines

  • conchita-marotz
  • 0 Slides

PARTNERSHIP. Medicines for Europe Vision 2020 . O...

Generating Information for Medicines Benefit Management:

Generating Information for Medicines Benefit Management:

  • natalia-silvester
  • 0 Slides

A Systems Framework. Dennis Ross-Degnan, ScD. Har...

Overview Antibiotics are precious life-saving medicines

Overview Antibiotics are precious life-saving medicines

  • debby-jeon
  • 0 Slides

Antimicrobial resistance is both a global and loc...

Access to essential medicines for NCDs

Access to essential medicines for NCDs

  • conchita-marotz
  • 0 Slides

WHO EMP and NVI Departments. Access to NCD essent...

All You Wanted to Know About the Drug FactS Label

All You Wanted to Know About the Drug FactS Label

  • tatyana-admore
  • 0 Slides

And more…. 1. What is the . Drug Facts Label. ?...

Economic characteristics

Economic characteristics

  • conchita-marotz
  • 0 Slides

of pharmaceuticals. .. Jamasoft2017. 1. Jamasoft2...

SADC Medicines Database (SMD)

SADC Medicines Database (SMD)

  • liane-varnes
  • 0 Slides

30 June 2016. Presentation Outline . Programme B...

B2 How medicines can be

B2 How medicines can be

  • liane-varnes
  • 0 Slides

sustainably and equitably financed. Summary Discu...

Overview of the African Medicines Regulatory

Overview of the African Medicines Regulatory

  • celsa-spraggs
  • 0 Slides

Harmonization and . African Medicines Agency. Mar...

The Future of HIV Treatment

The Future of HIV Treatment

  • myesha-ticknor
  • 0 Slides

Greg Perry. Melbourne – International AIDS Conf...

Improving access to medicines through local production:

Improving access to medicines through local production:

  • luanne-stotts
  • 0 Slides

Some New Development. I P C Meeting, Copenhagen (...

Local Production and A ccess to Medicines

Local Production and A ccess to Medicines

  • ellena-manuel
  • 0 Slides

EMP - Technical Briefing Seminar. . 1 November, ...

Review evidence to inform the health benefits package reform

Review evidence to inform the health benefits package reform

  • lois-ondreau
  • 0 Slides

in Vietnam. 1. Waranya Rattanavipapong. Yot Teera...

The International Pharmacopoeia

The International Pharmacopoeia

  • kittie-lecroy
  • 0 Slides

Dr Herbert Schmidt. Technologies, Standards and N...

Medicines benefits management policies and programs: updates

Medicines benefits management policies and programs: updates

  • giovanna-bartolotta
  • 0 Slides

Emmanuel Kwesi Eghan . Center . for Pharmaceutica...

Demand for ARV medicines in low and middle income countries will exceed 16 million person-years by

Demand for ARV medicines in low and middle income countries will exceed 16 million person-years by

  • natalia-silvester
  • 0 Slides

V. . Habiyambere. , . J. . Perriëns. , B. Dongmo...

INFORMATION ABOUT THE PHARMACEUTICAL SECTOR IN POLAND

INFORMATION ABOUT THE PHARMACEUTICAL SECTOR IN POLAND

  • tawny-fly
  • 0 Slides

T.U. . Federation of Chemical, Glass and Ceramic....

Regulatory capacity building and NDRA approvals of prequalified

Regulatory capacity building and NDRA approvals of prequalified

  • celsa-spraggs
  • 0 Slides

products. Milan . Smid. . Prequalification team ...

Opportunities & Challenges:

Opportunities & Challenges:

  • pasty-toler
  • 0 Slides

Expanding Access to Hepatitis C Treatment . Gregg...

MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS

MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS

  • cheryl-pisano
  • 0 Slides

Esteban Burrone, . July 2017. THE MEDICINES PATEN...

Procurement is a hot topic!

Procurement is a hot topic!

  • pamella-moone
  • 0 Slides

So is Supply Management – but for today we will...

WHO Prequalification Team – Need and contribution

WHO Prequalification Team – Need and contribution

  • debby-jeon
  • 0 Slides

Wednesday, 5 November . 2014. 13:35 – 15:45 . W...

An introduction to the work of Australia’s regulator of therapeutic goods

An introduction to the work of Australia’s regulator of therapeutic goods

  • luanne-stotts
  • 0 Slides

Therapeutic Goods Administration. Overview. Why d...

Developing Better Medicines at Lower

Developing Better Medicines at Lower

  • luanne-stotts
  • 0 Slides

Costs: The . Good Pharma Model. Speaker:. Donald ...

NEPAD Planning and Coordinating Agency

NEPAD Planning and Coordinating Agency

  • lois-ondreau
  • 0 Slides

Multiple-Stakeholder Partnerships for Medicines B...

Dr Samvel Azatyan Group Lead

Dr Samvel Azatyan Group Lead

  • lindy-dunigan
  • 0 Slides

Capacity Building and Harmonization Support. Regu...

Projecting the Impact of

Projecting the Impact of

  • marina-yarberry
  • 0 Slides

Generic. HIV . Drugs. on 90-90-90. Esteban Burr...

The Problem of Substandard Medicines in Developing Countries

The Problem of Substandard Medicines in Developing Countries

  • pasty-toler
  • 0 Slides

By Laura Christian, Linda Collins, . Maythiwan. ...

Prequalification as a Gateway to Global

Prequalification as a Gateway to Global

  • alida-meadow
  • 0 Slides

Markets. & . Performance of WHO . Prequalific...

Medicines Adaptive Pathways to Patients (MAPPs):

Medicines Adaptive Pathways to Patients (MAPPs):

  • debby-jeon
  • 0 Slides

Saving Time, Saving Lives. Thursday, 4 June 2015,...

Unit One Pre-test A Million Dollars Activity

Unit One Pre-test A Million Dollars Activity

  • min-jolicoeur
  • 0 Slides

Drug. What do you think of when you hear the word...

Where do they go? Destination Unknown: An exploratory study of the disposal of transdermal drug pat

Where do they go? Destination Unknown: An exploratory study of the disposal of transdermal drug pat

  • stefany-barnette
  • 0 Slides

L Breenª, H Zaman, A Mahmood, W Nabi, F . Mansoo...

CDI Module 14: Supply Chain Management for CDI

CDI Module 14: Supply Chain Management for CDI

  • pasty-toler
  • 0 Slides

©Jhpiego Corporation. The Johns Hopkins Universi...

CDI Module 14: Supply Chain Management for CDI

CDI Module 14: Supply Chain Management for CDI

  • danika-pritchard
  • 0 Slides

©Jhpiego Corporation. The Johns Hopkins Universi...

Copyright © 2024 DocSlides. All Rights Reserved